Unit 2: States of Matter & Physicochemical Properties

February 25, 2026

Semester 3
BP302T

Introduction to States of Matter & Physicochemical Properties

This unit covers the physical states of matter and their transitions, which are critical for understanding drug stability and storage. It also covers the key physicochemical properties (refractive index, optical rotation, dissociation constant) used in pharmaceutical analysis to identify and characterize drug substances.

Syllabus & Topics

  • 1States of Matter: Solid, Liquid, Gas – characteristics and differences.
  • 2Changes in State: Melting, Boiling, Sublimation, Condensation, Fusion.
  • 3Latent Heats: Latent heat of fusion (solid → liquid), Latent heat of vaporization (liquid → gas).
  • 4Vapour Pressure: Definition, factors affecting vapour pressure (temperature), Antoine equation.
  • 5Sublimation: Definition, pharmaceutical examples (Camphor, Iodine, Benzoic acid).
  • 6Critical Point: Critical temperature, critical pressure, critical volume. Above Tc, gas cannot be liquefied.
  • 7Eutectic Mixtures: Definition (mixture with lowest possible melting point), composition (eutectic point), pharmaceutical applications (transdermal formulations like EMLA = Lidocaine + Prilocaine eutectic).
  • 8Gases and Aerosols: Properties of ideal gases; Aerosols as colloidal systems; inhalers (MDI, DPI).
  • 9Relative Humidity (RH): Definition, importance in tablet storage and stability.
  • 10Liquid Complexes: Hydrates and solvates – effect on drug properties.
  • 11Liquid Crystals: Intermediate state between liquid and solid; Thermotropic (temperature-dependent) and Lyotropic (concentration-dependent) types; pharmaceutical applications (liposomes).
  • 12Glassy State (Amorphous Solids): No long-range order; metastable; higher energy than crystalline; higher solubility but lower stability.
  • 13Crystalline Solids: Long-range order; lower energy; more stable.
  • 14Polymorphism: Same chemical compound exists in different crystalline forms (polymorphs) with different physico-chemical properties (mp, solubility, bioavailability). Examples: Chloramphenicol palmitate (Form B active), Ranitidine (Form 1 and 2).
  • 15Physicochemical Properties – Refractive Index (η): Measurement (Abbé refractometer), applications (purity testing of oils and solutions).
  • 16Optical Rotation (α): Observed in chiral (optically active) compounds using polarimetry. [α]D = observed rotation/(l × c). Applications: assay of sugars, steroids, antibiotics.
  • 17Dielectric Constant (ε): Measure of a solvent’s polarity. High ε = polar solvent (Water: 78.5); Low ε = non-polar (Hexane: 1.9). Governs drug-solvent interactions.
  • 18Dipole Moment (μ): Measure of charge separation in a molecule. HF > HCl > HBr > HI.
  • 19Dissociation Constant (Ka or pKa): Measure of acid/base strength. pKa determines ionization state at physiological pH. Henderson-Hasselbalch equation.

Learning Objectives

Eutectic Mixtures: Give a pharmaceutical example of a eutectic mixture and its application.
Polymorphism: Explain the pharmaceutical significance of polymorphism with one drug example.
Refractive Index: State how refractive index is used in purity testing.
Optical Rotation: Define specific optical rotation and state the formula.
pKa: Explain why knowing a drug’s pKa is important for formulation design.

Frequently Asked Questions (FAQs)

Q1. What is a Eutectic Mixture?

A eutectic mixture is a combination of two or more components in a specific ratio (called the eutectic composition) that produces the lowest possible melting point compared to the individual components. At this composition, the mixture melts and solidifies at a single sharp temperature. For example, EMLA cream contains a 50:50 eutectic mixture of Lidocaine and Prilocaine, which liquefies at room temperature and enhances transdermal absorption.

Q2. What is Polymorphism in Pharmaceutical Science?

Polymorphism is the ability of a drug to exist in more than one crystalline form with different molecular packing arrangements. Although the chemical structure remains the same, polymorphs may differ in melting point, solubility, dissolution rate, and bioavailability. For example, Chloramphenicol palmitate exists as Form B (metastable and clinically active) and Form A (stable and inactive). Regulatory authorities require declaration and control of polymorphic forms to ensure consistent therapeutic performance.

Q3. What is Specific Optical Rotation?

Specific optical rotation is a physical constant used to identify chiral pharmaceutical substances and assess enantiomeric purity. It is expressed as [α]²⁰D = α/(l × c), where α is the observed rotation in degrees, l is the path length in decimeters, and c is the concentration in g/mL. It is commonly applied in the analysis of optically active drugs such as Levodopa and D-glucose.

Q4. What is the Difference Between Glassy (Amorphous) and Crystalline Solids?

Crystalline solids have a regular and ordered molecular arrangement, a sharp melting point, greater thermodynamic stability, and generally lower solubility. In contrast, amorphous (glassy) solids lack long-range molecular order, do not exhibit a sharp melting point, are metastable, and possess higher internal energy, which results in higher solubility but poorer physical stability since they may recrystallize over time.

Q5. What is Dielectric Constant and Why Does It Matter?

Dielectric constant (ε) is a measure of a solvent’s ability to store electrical energy and separate charges. Solvents with a high dielectric constant, such as Water (ε = 78.5), are highly polar and dissolve ionic or polar drugs effectively, whereas solvents with a low dielectric constant (e.g., oils, ε ≈ 3–5) are non-polar and dissolve non-polar drugs. Understanding dielectric constant is essential for proper solvent and co-solvent selection in pharmaceutical formulations.